BioVaxys Technology Corp. (CSE: BIOV)
Canada
· Delayed Price · Currency is CAD 0.0650
-0.0050 (-7.14%)
Nov 22, 2024, 4:00 PM EST
BioVaxys Technology Market Cap
BioVaxys Technology has a market cap or net worth of CAD 18.94 million as of November 22, 2024. Its market cap has increased by 411.82% in one year.
Market Cap
18.94M
Enterprise Value
18.53M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since October 6, 2020, BioVaxys Technology's market cap has decreased from 27.06M to 18.94M, a decrease of -30.00%. That is a compound annual growth rate of -8.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 22, 2024 | 18.94M | 161.03% |
| Dec 29, 2023 | 7.26M | -47.89% |
| Dec 30, 2022 | 13.92M | -26.37% |
| Dec 31, 2021 | 18.91M | 32.10% |
| Dec 31, 2020 | 14.32M | -47.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries Inc. | 3.19B |
| Trulieve Cannabis Corp. | 1.68B |
| Cresco Labs Inc. | 581.17M |
| Grown Rogue International Inc. | 215.77M |
| Planet 13 Holdings Inc. | 185.34M |
| Ayr Wellness Inc. | 120.83M |
| Jushi Holdings Inc. | 99.36M |
| MariMed Inc. | 84.85M |